Cencora earnings were $2.6B for the trailing 12 months ending Jun 30, 2026, with 37.8% growth year over year. The latest COR earnings report on Jun 30, 2026 announced Q2 2026 earnings of $763.5M, down 53.5% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, COR reported annual earnings of $1.6B, with 3% growth.
COR past earnings growth
How has COR's earnings growth performed historically?
On COR's earnings call on Aug 5, 2026, Cencora (NYSE: COR) reported Q2 2026 earnings per share (EPS) of $3.95, up 11.27% year over year. Total COR earnings for the quarter were $763.52 million. In the same quarter last year, Cencora's earnings per share (EPS) was $3.55.
As of the last Cencora earnings report, Cencora is currently profitable. Cencora's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $2.62 billion, a 38.35% increase year over year.
What was COR's earnings growth in the past year?
As of Cencora's earnings date in Aug 5, 2026, Cencora's earnings has grown 37.82% year over year. This is 2.56 percentage points higher than the US Medical Distribution industry earnings growth rate of 35.25%. COR earnings in the past year totalled $2.62 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.